Rhythm Pharmaceuticals Inc (RYTM)
38.16
-1.55
(-3.90%)
USD |
NASDAQ |
Apr 25, 16:00
38.16
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Total Liabilities (Quarterly): 162.99M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 162.99M |
| September 30, 2023 | 156.72M |
| June 30, 2023 | 127.66M |
| March 31, 2023 | 125.92M |
| December 31, 2022 | 118.22M |
| September 30, 2022 | 108.42M |
| June 30, 2022 | 82.05M |
| March 31, 2022 | 49.06M |
| December 31, 2021 | 45.37M |
| September 30, 2021 | 33.56M |
| June 30, 2021 | 36.70M |
| March 31, 2021 | 41.26M |
| December 31, 2020 | 20.54M |
| September 30, 2020 | 18.54M |
| Date | Value |
|---|---|
| June 30, 2020 | 17.73M |
| March 31, 2020 | 20.66M |
| December 31, 2019 | 27.50M |
| September 30, 2019 | 28.42M |
| June 30, 2019 | 29.42M |
| March 31, 2019 | 16.01M |
| December 31, 2018 | 13.95M |
| September 30, 2018 | 8.091M |
| June 30, 2018 | 7.432M |
| March 31, 2018 | 5.785M |
| December 31, 2017 | 6.948M |
| September 30, 2017 | 5.71M |
| June 30, 2017 | 5.113M |
| December 31, 2016 | 5.042M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.73M
Minimum
Jun 2020
162.99M
Maximum
Dec 2023
65.83M
Average
41.26M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 137.21B |
| Insmed Inc | 1.662B |
| Altimmune Inc | 16.54M |
| Regeneron Pharmaceuticals Inc | 7.107B |
| Viking Therapeutics Inc | 20.07M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 332.74M |
| Shareholders Equity (Quarterly) | 169.76M |
| Current Ratio | 5.584 |